Heparin administration increases plasma warfarin binding in man. 1979

P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
August 1986, Clinical chemistry,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
February 1980, British journal of clinical pharmacology,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
August 1974, The Tohoku journal of experimental medicine,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
August 1997, Arteriosclerosis, thrombosis, and vascular biology,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
December 1985, British journal of clinical pharmacology,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
October 1979, British journal of clinical pharmacology,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
February 1977, Biochemical pharmacology,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
April 1961, Circulation,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
January 1971, Thrombosis et diathesis haemorrhagica,
P A Routledge, and T D Bjornsson, and B B Kitchell, and D G Shand
December 1977, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!